Biotivia Biceuticals has entered into a collaboration with the University of Ferrara to investigate the potential theraputic effects of its proprietary Resveratrol on Beta Thalassemia patients at two hospitals in Italy and one in Egypt. The Thal Lab, under the university’s department of Biochemistry and Molecular Biology, is headed by Dr. Roberto Gambari, physician, professor and acknowledged world expert on Thalassemia, Cystic Fibrosis and Sickle Cell Anemia. He will design, manage and analyze the human clinical trials to begin in the last quarter of 2010.
Biotivia Blog
- Recent Articles
- Free Radical Theory Of Aging: Is Your Body Under Attack?
- The Biology of Aging: Implications for Diseases of Aging and Healthcare in the 21st Century
- Mike Adams Resveratrol Report
- Study Suggests That Resveratrol May Be Key In Ageing Process
- New Resveratrol Capsules Introduced In Britain
- Resveratrol shown in study to combat aging
- Resveratrol Popularity Grows Internationally
- Resveratrol May Lead to a Decrease in Body Fat
- Acai extracts show brain health and cognitive potential
- Biotivia Launch The World’s First Pterostilbene Supplement
Resveratrol could help Thalassemia sufferers
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.
1-866-459-2773 (24/7)
